Prediction of Biomarkers and Therapeutic Combinations for Anti-PD-1 Immunotherapy Using the Global Gene Network Association

Prediction identified genes and pathways known to be associated with anti-PD1, and was further validated by six CRISPR gene sets associated with tumor resistance to cytotoxic T cells and targets of the 36 compounds that had been tested in clinical trials for combination treatments with anti-PD1.